Healionics: Funding, Investors & Team (Oct 2026)
Healionics is a clinical-stage company that aims to provide a safer and more dependable method of bloodstream access for dialysis in patients with kidney failure. To address the issues of infection and blockage experienced by existing devices, we have developed the STARgraft vascular graft, a synthetic blood vessel. Additionally, our STAR® biomaterial, which forms the basis of our product pipeline, has the exceptional capability to prevent scarring and infection in all types of implantable devices. At present, Healionics is actively conducting human studies on STARgraft and holds 33 patents, with more pending.
Healionics has raised $7.4M across 2 funding rounds on record, the most recent an undisclosed round of $2.7M announced in Nov 2023.
That round is below the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Healionics Company Profile and Key Stats
Latest funding round on record: Nov 2023.
Healionics Funding Rounds
Healionics raised $4.7M in an undisclosed round announced in May 2021.
2.5 years later, an undisclosed round of $2.7M was announced in Nov 2023.
Healionics Founders and Leadership Team
Contact details for the Healionics team: 1 of 1 has an email address on file.
Start 14-day free trial →Healionics Funding Compared to Other Biotechnology Startups
Healionics' latest round of $2.7M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Healionics in Biotechnology and Seattle
Companies Similar to Healionics
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…
Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…
Datavant is a developer of a healthcare data platform dedicated to assisting in protecting, matching, and…
Healionics Funding FAQs
What does Healionics do?
Healionics is a clinical-stage company that aims to provide a safer and more dependable method of bloodstream access for dialysis in patients with kidney failure. To address the issues of infection and blockage experienced by existing devices, we have developed the STARgraft vascular graft, a synthetic blood vessel. Additionally, our STAR® biomaterial, which forms the basis of our product pipeline, has the exceptional capability to prevent scarring and infection in all types of implantable devices. At present, Healionics is actively conducting human studies on STARgraft and holds 33 patents, with more pending.
How much funding has Healionics raised?
Healionics has raised $7.4M across 2 rounds on record. The most recent is an undisclosed round of $2.7M announced in Nov 2023.
When did Healionics last raise funding?
Healionics' most recent funding round on record is an undisclosed round of $2.7M, announced in Nov 2023.
Who is the CEO of Healionics?
Mike Connolly is listed as CEO at Healionics.
Where is Healionics headquartered?
Healionics is based in Seattle, Washington, United States.
How many employees does Healionics have?
Healionics is in the 1-10 employee band.
How does Healionics' funding compare to other Biotechnology startups?
Healionics' latest round of $2.7M is below the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Healionics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Healionics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.